187 related articles for article (PubMed ID: 16093004)
1. [Analysis of the prognosis of severe hepatitis treated with molecular adsorbent recycling system (MARS) using MELD score].
Sun LH; Zhang YX; Xiao L; Lu XB
Zhonghua Gan Zang Bing Za Zhi; 2005 Aug; 13(8):632, 635. PubMed ID: 16093004
[No Abstract] [Full Text] [Related]
2. Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure.
Di Campli C; Santoro MC; Gaspari R; Merra G; Zileri Dal Verme L; Zocco MA; Piscaglia AC; Di Gioacchino G; Novi M; Santoliquido A; Flore R; Tondi P; Proietti R; Gasbarrini G; Pola P; Gasbarrini A
Transplant Proc; 2005; 37(6):2547-50. PubMed ID: 16182739
[TBL] [Abstract][Full Text] [Related]
3. Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment.
Yu JW; Sun LJ; Zhao YH; Li SC
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1242-9. PubMed ID: 18637053
[TBL] [Abstract][Full Text] [Related]
4. [Study of severe hepatitis treated with a hybrid artificial liver support system].
Li LJ; Yang Q; Huang JR; Li J; Cao HC; Chen YM; Chen YG; Cheng JF; Fu SZ
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):458-60. PubMed ID: 12939173
[TBL] [Abstract][Full Text] [Related]
5. [Improvement of molecular adsorbent recirculating system on chronic severe hepatitis patients with multiple organ failure].
Hu XB; Yang Z; Tang XP; Wang MM; Zhou Y; Li SP
Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):629-30. PubMed ID: 14572350
[No Abstract] [Full Text] [Related]
6. [Treatment of severe liver damage with autologous bone marrow stem cell transplantation in human patients].
Yao P; Hu DR; Wang S; Wen W; Zhou YM; Gong LJ
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):941-2. PubMed ID: 16381648
[No Abstract] [Full Text] [Related]
7. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
Wang ZX; Yan LN; Wang WT; Xu MQ; Yang JY
Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172
[TBL] [Abstract][Full Text] [Related]
8. Short-term entecavir therapy of chronic severe hepatitis B.
Chen J; Han JH; Liu C; Yu RH; Li FZ; Li QF; Gong GZ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):261-6. PubMed ID: 19502165
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with molecular adsorbent recirculating system (MARS) in patients with drug-induced liver failure.
Zhou XM; Miao JY; Yang Y; Zhao L; Wang X; Xu L; Ding J; Wu KC; Fan DM; Wang MM
Artif Organs; 2004 May; 28(5):483-6. PubMed ID: 15113343
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.
Sun QF; Ding JG; Xu DZ; Chen YP; Hong L; Ye ZY; Zheng MH; Fu RQ; Wu JG; Du QW; Chen W; Wang XF; Sheng JF
J Viral Hepat; 2009 Jul; 16(7):464-70. PubMed ID: 19413694
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular adsorbent recirculating system.
Tan HK; Yang WS; Chow P; Lui HF; Choong HL; Wong KS
Artif Organs; 2007 Mar; 31(3):193-9. PubMed ID: 17343694
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of efficacy and safety of using molecular adsorbent recirculating system in the treatment of patients with chronic liver failure].
Lu XB; Xiao L; Zhang YX; Liu H; Yan GX; Xu L; Sun LH
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jan; 19(1):44-6. PubMed ID: 17207365
[TBL] [Abstract][Full Text] [Related]
13. Cytokines and liver failure: modification of TNF- and IL-6 in patients with acute on chronic liver decompensation treated with Molecular Adsorbent Recycling System (MARS).
Ambrosino G; Naso A; Feltracco P; Carraro P; Basso SM; Varotto S; Cillo U; Zanus G; Boccagni P; Brolese A; Plebani M; Giron G; D'Amico DF
Acta Biomed; 2003; 74 Suppl 2():7-9. PubMed ID: 15055025
[TBL] [Abstract][Full Text] [Related]
14. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B.
Cai CJ; Chen HA; Lu MQ; Chen GH
Chin Med J (Engl); 2008 Oct; 121(20):2065-9. PubMed ID: 19080277
[TBL] [Abstract][Full Text] [Related]
15. The use of the molecular adsorbent recirculating system (MARS) albumin dialysis for the treatment of liver failure: a nursing perpective.
McCready R
Dynamics; 2009; 20(3):18-22. PubMed ID: 19953756
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of short-term prognosis on patients with chronic severe hepatitis B using the model for end-stage liver disease].
Zhou J; He WF; Tang XE
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):416-8. PubMed ID: 17631710
[TBL] [Abstract][Full Text] [Related]
17. [Effect of artificial liver support system on the patients with severe hepatitis].
Li CZ; Tan DM; Liu SH
Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):377-8. PubMed ID: 12536744
[TBL] [Abstract][Full Text] [Related]
18. Successful MARS treatment in severe cholestatic patients with acute on chronic liver failure.
Campli CD; Gaspari R; Mignani V; Stifano G; Santoliquido A; Verme LZ; Proietti R; Pola P; Silveri NG; Gasbarrini G; Gasbarrini A
Artif Organs; 2003 Jun; 27(6):565-9. PubMed ID: 12780511
[TBL] [Abstract][Full Text] [Related]
19. Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure.
Lee KH; Lee MK; Sutedja DS; Lim SG
Liver Int; 2005 Oct; 25(5):973-7. PubMed ID: 16162155
[TBL] [Abstract][Full Text] [Related]
20. [Clinical value of the model for end-stage liver disease score in predicting the prognosis of liver transplantation in patients with end-stage liver disease].
Sun J; Guo ZH; Lai TS; Tang YQ; Su L; Huo F; Wang SP; Pu MS; Wen Q
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1731-2, 1742. PubMed ID: 18819907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
